To further explore the DKK1 pathway in the cisplatin-refractory phenotype of NSCLC cells and to delineate putative mechanisms, Ingenuity Pathway Analysis (IPA) was used to map upstream regulating and downstream proteins of DKK1 (Fig. 4). The gene discussed is DKK1; the disease is non-small cell lung carcinoma.